The 50 most-backed specifically named diseases in the United States are ranked by their centrality in the sector's funding network — a measure of how embedded they are through grants received, board connections, and shared funders.
The largest are Breakthrough T1D, American Diabetes Association Inc, and Joslin Diabetes Center Inc.
Ranked by sector centrality (ImpactRank over the funder graph).